Pediatric JAK Inhibitor Use and Height in Common Inflammatory Diseases
This cohort study evaluates the association between Janus kinase (JAK) inhibitor use and height in pediatric patients with atopic dermatitis, juvenile idiopathic arthritis, and inflammatory bowel disease.
Authors
- Hannah L. Cole (ORCID: https://orcid.org/0000-0002-3023-8998)
- John S. Barbieri (ORCID: https://orcid.org/0000-0002-5467-4102)
- Lisa Y. Shen (ORCID: https://orcid.org/0000-0002-4112-278X)
Institutions
- Boston University (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1001/jamadermatol.2025.3934
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00